Get Vaccine Safety & AvailabilityVaccine Safety Questions And Answers

Vaccine Safety: An interinstitutional work The monitoring of adverse events after the administration of vaccines generates useful information on rare and very rare adverse events, and on risks related to the quality and handling of vaccines.

Chickenpox (Varicella) Diphtheria. Flu (Influenza) Hepatitis A. Hepatitis B. Hib. HPV (Human Papillomavirus) Measles.

Information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation. Signals are generated from several sources such as spontaneous reports, clinical studies and the scientific literature. More information can be found under 'Signal management'.

We can describe the safety signal as an indication for new and significant safety-related data for a marketed product. The new data could indicate a new potentially causal association between an adverse event, beneficial response and a medical product, or a new aspect of causal association that was previously known.

VAERS is an early-warning monitoring system for vaccine safety. It allows patients, pharmaceutical companies, medical personnel and other users to report concerns about medical events that occurred after someone received a vaccination.

Once vaccines are introduced and used in countries, national health authorities continuously monitor vaccine safety to detect and immediately respond to potential concerns. In case of an adverse event, an independent group of experts assesses whether such an event is related to vaccines.

A vaccine safety signal is information that indicates a potential link between a vaccine and an event previously unknown or incompletely documented, that could affect health.

Once vaccines are introduced and used in countries, national health authorities continuously monitor vaccine safety to detect and immediately respond to potential concerns. In case of an adverse event, an independent group of experts assesses whether such an event is related to vaccines.